Clinical Trial Update: Impact of Misoprostol on Blood Loss In Myomectomy Operations [Phase 3]

View source ↗

Summary

This Phase 3 trial update assesses the impact of misoprostol on blood loss during myomectomy in women with leiomyoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyoma

Drugs mentioned

• MISOPROSTOL (Misoprostol)

Snippet

Sponsor: Ain Shams University | Conditions: Leiomyoma | Phase 3 | Status: COMPLETED